Post-Marketing Surveillance

  • J. P. Griffin
Part of the NATO Advanced Study Institutes Series book series (NSSA, volume 39)


The term post-marketing surveillance is a term which should be applied to all forms of monitoring marketed drugs for all aspects of their potential to produce adverse reactions.


Product Defect Yellow Card Microbiological Contamination Medicine Division Adverse Reaction Reporting 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Griffin J P and D’ Arcy P F (1981) Adverse Reactions to Drugs - The Information Lag in Side Effects of Drugs Annual No 5, Edited N M G Dukes Excerpta Medica Amsterdam (in press).Google Scholar
  2. Laufer R D (1980) The Medical Literature as an Adverse Drug Reaction Warning System. Appendix VI of “Report of Joint Commission on Prescription Drug Use”(USA)Google Scholar
  3. Watkins S M and Griffin J P (1978) High Incidence of Vincristine- induced Neuropathy in Lymphomas. Br Med J 1, 610–612.PubMedCrossRefGoogle Scholar
  4. Williams J R B, Griffin J P and Parkins A (1976) Effect of Concomitantly Administered Drugs on the Control of Long Term Anticoagulant therapy. Quart J Med 177 63–73.Google Scholar

Copyright information

© Springer Science+Business Media New York 1981

Authors and Affiliations

  • J. P. Griffin
    • 1
  1. 1.Department of Health and Social SecurityLondonUK

Personalised recommendations